NDC Code(s) : 10267-1122-1, 10267-1122-4
Packager : Contract Pharmacal Corp

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Natural Senna Sennosides TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:10267-1122
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SENNOSIDES A AND B(UNII: 1B5FPI42EN)
(SENNOSIDES - UNII:3FYP5M0IJX) 		SENNOSIDES A AND B8.6 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM(UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE(UNII: O7TSZ97GEP)
HYPROMELLOSES(UNII: 3NXW29V3WO)
MAGNESIUM SILICATE(UNII: 9B9691B2N9)
MAGNESIUM STEARATE(UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE(UNII: OP1R32D61U)
LIGHT MINERAL OIL(UNII: N6K5787QVP)
POLYETHYLENE GLYCOL 400(UNII: B697894SGQ)
Product Characteristics
Color BROWN (Mottled brown) Score no score
Shape ROUND Size 9 mm
Flavor Imprint Code 1122
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:10267-1122-1100 in 1 BOTTLE
2NDC:10267-1122-41000 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part334 01/24/2001

PRINCIPAL DISPLAY PANEL

f4a8921b-figure-01